There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...

The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

UNM scientists have developed a promising tau-targeting vaccine for Alzheimer’s, showing strong immune responses in animals ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...